Medicinova (MNOV) Free Cash Flow (2010 - 2025)
Medicinova (MNOV) posted quarterly Free Cash Flow of -$2.0 million for Q4 2025, down 4.4% year-over-year from -$2.1 million in Q4 2024, and down 18.41% quarter-over-quarter from -$1.7 million in Q3 2025.
Medicinova (MNOV) Free Cash Flow (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has reported Free Cash Flow for 16 consecutive years, with -$2.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Free Cash Flow fell 4.4% year-over-year to -$2.0 million; the TTM figure through Dec 2025 stood at -$9.8 million (up 7.83% YoY), while the FY2025 annual figure was -$9.8 million, up 7.81% from the prior year.
- Free Cash Flow retreated to -$2.0 million in Q4 2025 per MNOV's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $1.1 million in Q2 2021 and bottomed at -$4.0 million in Q4 2022.
- Historically, Free Cash Flow has averaged -$2.5 million across 5 years, with a median of -$2.6 million in 2022.
- Annual changes were most pronounced in 2021 — Free Cash Flow surged 153.91% — and 2022, when it slumped 317.93%.
- Medicinova's Free Cash Flow stood at -$3.6 million in 2021, then dropped by 10.11% to -$4.0 million in 2022, then surged by 87.55% to -$499038.0 in 2023, then slumped by 287.09% to -$1.9 million in 2024, then dropped by 4.4% to -$2.0 million in 2025.
- Business Quant data shows MNOV's Free Cash Flow at -$2.0 million in Q4 2025, -$1.7 million in Q3 2025, and -$2.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.02 Mn |
| Dec 31, 2025 | -2.02 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Jun 30, 2025 | -2.31 Mn |
| Jun 30, 2025 | -2.31 Mn |
| Mar 31, 2025 | -3.78 Mn |
| Mar 31, 2025 | -3.78 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Sep 30, 2024 | -2.03 Mn |
| Sep 30, 2024 | -2.03 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Mar 31, 2024 | -3.87 Mn |
| Mar 31, 2024 | -3.87 Mn |
| Dec 31, 2023 | -499,038.00 |
| Dec 31, 2023 | -499,038.00 |
| Sep 30, 2023 | -1.37 Mn |
| Sep 30, 2023 | -1.37 Mn |